Gibraltar Capital Management raised its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The hedge fund owned 43,190 shares of the pharmacy operator’s stock after buying an additional 3,015 shares during the period. Walgreens Boots Alliance accounts for 4.6% of Gibraltar Capital Management’s portfolio, making the stock its 11th largest position. Gibraltar Capital Management’s holdings in Walgreens Boots Alliance were worth $3,678,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of WBA. Janus Capital Management increased its stake in shares of Walgreens Boots Alliance by 35.5% in the third quarter. Janus Capital Management now owns 1,324,869 shares of the pharmacy operator’s stock valued at $110,097,000 after buying an additional 346,993 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft bought a new stake in shares of Walgreens Boots Alliance during the third quarter valued at $19,336,000. Hillman Company bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at $17,968,216. MUFG Americas increased its stake in shares of Walgreens Boots Alliance by 10.0% in the third quarter. MUFG Americas now owns 98,191 shares of the pharmacy operator’s stock valued at $8,160,000 after buying an additional 8,897 shares in the last quarter. Finally, Quotient Investors increased its stake in shares of Walgreens Boots Alliance by 179.2% in the fourth quarter. Quotient Investors now owns 13,400 shares of the pharmacy operator’s stock valued at $1,141,000 after buying an additional 8,600 shares in the last quarter.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at 78.5201 on Thursday. The stock has a 50 day moving average price of $82.37 and a 200 day moving average price of $86.79. The firm has a market capitalization of $84.70 billion and a price-to-earnings ratio of 19.1186. Walgreens Boots Alliance Inc has a 1-year low of $73.00 and a 1-year high of $97.30.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, January 7th. The pharmacy operator reported $1.03 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.96 by $0.07. The firm earned $29 billion during the quarter, compared to analyst estimates of $29.24 billion. The business’s revenue for the quarter was up 48.5% compared to the same quarter last year. Analysts predict that Walgreens Boots Alliance Inc will post $4.48 EPS for the current year.

A number of equities research analysts have commented on the company. Raymond James raised Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating in a report on Monday, November 16th. Barclays reduced their target price on Walgreens Boots Alliance from $86.00 to $81.00 and set an “equal weight” rating for the company in a report on Thursday, October 29th. Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, December 23rd. Jefferies Group raised their target price on Walgreens Boots Alliance from $90.00 to $105.00 and gave the company a “hold” rating in a report on Wednesday, October 28th. Finally, Evercore ISI raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.50 target price for the company in a report on Wednesday, January 6th. Six analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus target price of $96.86.

In other Walgreens Boots Alliance news, Director John Anthony Lederer purchased 10,000 shares of the company’s stock in a transaction that occurred on Monday, November 2nd. The shares were purchased at an average cost of $84.88 per share, with a total value of $848,800.00. Following the completion of the transaction, the director now owns 20,000 shares of the company’s stock, valued at $1,697,600. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 3,500 shares of the company’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $88.36, for a total value of $309,260.00. Following the transaction, the director now directly owns 30,823 shares in the company, valued at $2,723,520.28. The disclosure for this sale can be found here.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand). In addition, the Company has investments in Guangzhou Pharmaceuticals Corporation and Nanjing Pharmaceutical Company Limited. The Company operates in around 25 countries, which include the wholesale and distribution network with over 340 distribution centers and more than 180,000 pharmacies, health centers and hospitals in 19 countries.

12 Month Chart for NASDAQ:WBA

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.